share_log

Aptorum Therapeutics Granted U.S. Patent #12023334: Composition Including Rilpivirine And Method For Treating Tumors Or Cancer

Benzinga ·  Jul 3 01:15
Aptorum Therapeutics Granted U.S. Patent #12023334: Composition Including Rilpivirine And Method For Treating Tumors Or Cancer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment